As shown in Figure 7, the anti-PSMA Ab specifically directs NK cells to PCa sites by simultaneously binding to the specific antigen PSMA on the PCa cell surface and CD16 on the NK cell surface, activating NK cells to display potent anti-tumor activity. This evidence concerns the gene FCGR3A and posterior cortical atrophy.